IP Library Granted Patent US 11,707,624
Granted Patent B2
US 11,707,624 · App. 17/323,821 · Granted Jul 25, 2023

Methods and systems for treating cardiovascular disease using an implantable electroacupuncture device

Inventors: Jeffrey H. Greiner (Valencia, CA); David K. L. Peterson (Valencia, CA); Chuladatta Thenuwara (Castaic, CA)
Assignee: Valencia Bioscience, Inc.
A61N1/36114A61H39/00A61H39/002A61N1/36117A61N1/36125A61N1/36175A61N1/3756A61N1/37205A61N1/37223A61H2201/01A61N1/36153A61N1/36157A61N1/3782A61N1/3787Y10T29/49002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,707,624
App. No.
17/323,821
Granted
Jul 25, 2023
Kind
B2
Abstract

A method of treating cardiovascular disease in a patient includes generating, by an implantable stimulator configured to be implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a location, within the patient, that is associated with the cardiovascular disease. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes.

Claims (34)

1. A method of treating cardiovascular disease in a patient, comprising:

generating, by an implantable stimulator, stimulation sessions at a duty cycle that is less than 0.05, wherein

the duty cycle is a ratio of T3 to T4,

each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes, and

the implantable stimulator comprises a central electrode of a first polarity centrally located on a first surface of a housing of the implantable stimulator and an annular electrode of a second polarity and that is spaced apart from the central electrode; and

applying, by the implantable stimulator, the stimulation sessions by way of the central electrode and the annular electrode to a location, within the patient, that is associated with the cardiovascular disease.

2. The method of claim 1 , wherein the implantable stimulator is powered by a rechargeable battery.

3. The method of claim 2 , further comprising receiving, by the implantable stimulator from an external controller, a power signal configured to recharge the rechargeable battery.

4. The method of claim 1 , wherein the implantable stimulator is powered by a primary battery.

5. The method of claim 4 , wherein the primary battery has an internal impedance greater than 5 ohms.

6. The method of claim 1 , wherein the housing of the implantable stimulator is coin-sized and coin-shaped.

7. The method of claim 1 , wherein the annular electrode is located on the first surface of the housing.

8. The method of claim 1 , wherein the annular electrode comprises a ring electrode located around a perimeter edge of the housing.

9. The method of claim 1 , wherein T3 is at least 10 minutes and less than 60 minutes, and wherein T4 is at least 1440 minutes.

10. The method of claim 1 , wherein the location comprises a median nerve of the patient.

11. The method of claim 1 , wherein the implantable stimulator is configured to be implanted at an acupoint PC6.

12. An implantable stimulator for treating cardiovascular disease in a patient, comprising:

a housing;

a central electrode of a first polarity and centrally located on a first surface of the housing;

an annular electrode of a second polarity and that surrounds the central electrode on the first surface of the housing, the annular electrode being spaced apart from the central electrode; and

pulse generation circuitry located within the housing, the pulse generation circuitry configured to

generate stimulation sessions at a duty cycle that is less than 0.05, and

apply the stimulation sessions to a location, within the patient, that is associated with the cardiovascular disease;

wherein

the duty cycle is a ratio of T3 to T4, and

each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes.

13. The implantable stimulator of claim 12 , further comprising a rechargeable battery within the housing and configured to provide power to the pulse generation circuitry.

14. The implantable stimulator of claim 13 , further comprising a receiver circuit within the housing and configured to receive, from an external controller, a power signal configured to recharge the rechargeable battery.

15. The implantable stimulator of claim 12 , further comprising a primary battery within the housing and configured to provide power to the pulse generation circuitry.

16. The implantable stimulator of claim 15 , wherein the primary battery has an internal impedance greater than 5 ohms.

17. The implantable stimulator of claim 12 , wherein the housing of the implantable stimulator is coin-sized and coin-shaped.

18. The implantable stimulator of claim 12 , wherein the annular electrode is located on the first surface of the housing.

19. The implantable stimulator of claim 12 , wherein the annular electrode comprises a ring electrode located around a perimeter edge of the housing.

20. The method of claim 1 , wherein the location comprises a median nerve of the patient.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded May 6, 2026
From: MEDTRONIC, INC.
To: VALENCIA BIOSCIENCE, INC.
Reel/Frame 075721/0223 →
SECURITY INTEREST Recorded Oct 27, 2023
From: VALENCIA BIOSCIENCE, INC.
To: MEDTRONIC, INC.
Reel/Frame 065382/0738 →
SECURITY INTEREST Recorded Aug 4, 2021
From: VALENCIA BIOSCIENCE, INC.
To: MEDTRONIC, INC.
Reel/Frame 057088/0352 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2021
From: GREINER, JEFFREY H.; PETERSON, DAVID K.L.; THENUWARA, CHULADATTA
To: VALENCIA TECHNOLOGIES CORPORATION
Reel/Frame 056279/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2021
From: VALENCIA TECHNOLOGIES CORPORATION
To: VALENCIA BIOSCIENCE, INC.
Reel/Frame 056279/0253 →
Continuity (14)
Continuation 16394902 · Apr 25, 2019
Continuation 15421267 · Jan 31, 2017
Continuation 14805346 · Jul 21, 2015
Continuation 14669155 · Mar 26, 2015
Division 13622653 · Sep 19, 2012
Provisional Application 61626339 · Sep 23, 2011
Provisional Application 61606995 · Mar 6, 2012
Provisional Application 61609875 · Mar 12, 2012
Provisional Application 61672257 · Jul 16, 2012
Provisional Application 61672661 · Jul 17, 2012
Provisional Application 61673254 · Jul 19, 2012
Provisional Application 61674691 · Jul 23, 2012
Provisional Application 61676275 · Jul 26, 2012
Related Publication 20210268287A1 · Sep 2, 2021